KCNK10.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|--------------------------------------|
19
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
19
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
MME.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|--------------------------------------|
19
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
19
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
MTOR.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description |
22 22
|:------:|:----:|--------------------------------------|
23
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
23
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
24 24
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene |
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)